Table 2.
Change in laboratory values between baseline and outcome clinic visits.
| Group | Baseline | Outcome | p value | |
|---|---|---|---|---|
| ALT (U/L) | NAFLD3M | 100 (90) | 75 (54) | 0.02 |
| HEP1Y | 101 (81) | 85 (70) | 0.09 | |
| AST (U/L) | NAFLD3M | 57 (43) | 44 (27) | 0.03 |
| HEP1Y | 60 (35) | 52 (40) | 0.11 | |
| GGT (U/L) | NAFLD3M | 41 (30) | 31 (18) | <0.01 |
| HEP1Y | 63 (53) | 57 (48) | 0.07 | |
| ALP (U/L) | NAFLD3M | 247 (107) | 206 (89) | <0.01 |
| HEP1Y | 238 (95) | 212 (96) | 0.05 | |
| LDL (mmol/L) | NAFLD3M | 2.5 (0.6) | 2.5 (0.6) | 0.38 |
| HEP1Y | 2.9 (0.1) | 2.7 (0.3) | 0.19 | |
| HDL (mmol/L) | NAFLD3M | 1.2 (0.3) | 1.1 (0.3) | 0.36 |
| HEP1Y | 0.9 (0.1) | 0.9 (0.1) | 0.25 | |
| Total cholesterol (mmol/L) | NAFLD3M | 4.4 (0.8) | 4.3 (0.7) | 0.19 |
| HEP1Y | 5.2 (1.1) | 5.0 (1.3) | 0.53 | |
| Triglycerides (mmol/L) | NAFLD3M | 1.3 (0.8) | 1.4 (1.0) | 0.56 |
| HEP1Y | 2.1 (1.3) | 1.7 (1.0) | 0.37 | |
| PLT (×109/L) | NAFLD3M | 288 (49) | 290 (62) | 0.88 |
| HEP1Y | 326 (55) | 316 (56) | 0.33 |
Data are expressed as means (SD).